Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Obstet Gynecol

Retrieve available abstracts of 76 articles:
HTML format



Single Articles


    November 2021
  1. MAGNUSSON BM, Christensen SR, Tanner AB, Eyring JB, et al
    Accessibility of Pharmacist-Prescribed Contraceptives in Utah.
    Obstet Gynecol. 2021 Nov 4. pii: 00006250-990000000-00334.
    PubMed     Abstract available


    October 2021
  2. BRANT AR, Kollikonda S, Yao M, Mei L, et al
    Use of Immediate Postpartum Long-Acting Reversible Contraception Before and After a State Policy Mandated Inpatient Access.
    Obstet Gynecol. 2021 Oct 7. pii: 00006250-990000000-00308.
    PubMed     Abstract available


  3. BURLANDO AM, Flynn AN, Gutman S, McAllister A, et al
    The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Obstet Gynecol. 2021;138:574-577.
    PubMed     Abstract available


    August 2021
  4. WU JP, Zhang J, McKee M, Akobirshoev I, et al
    Contraceptive Provision and Quality Care Measures for Insured Individuals in Massachusetts Who Are Deaf or Hard of Hearing.
    Obstet Gynecol. 2021 Aug 5. pii: 00006250-990000000-00251.
    PubMed     Abstract available


  5. SCHAUB AM, Pisarska MD, Wright KN
    Intrauterine Adhesions After Chlamydia Infection With a Levonorgestrel-Releasing Intrauterine Device in Place.
    Obstet Gynecol. 2021 Aug 5. pii: 00006250-990000000-00258.
    PubMed     Abstract available



  6. Access to Postabortion Contraception: ACOG Committee Opinion, Number 833.
    Obstet Gynecol. 2021;138:e91-e95.
    PubMed     Abstract available



  7. Access to Postabortion Contraception: ACOG Committee Opinion Summary, Number 833.
    Obstet Gynecol. 2021;138:324-325.
    PubMed     Abstract available


    July 2021
  8. BAKENRA A, Gero A, Sanders J, Simmons R, et al
    Pregnancy Risk by Frequency and Timing of Unprotected Intercourse Before Intrauterine Device Placement for Emergency Contraception.
    Obstet Gynecol. 2021;138:79-84.
    PubMed     Abstract available


  9. ARORA KS, Ponsaran R, Morello L, Katabi L, et al
    Obstetrician-Gynecologists' Practices in Postpartum Sterilization Without a Valid Medicaid Consent Form.
    Obstet Gynecol. 2021;138:66-72.
    PubMed     Abstract available


    June 2021

  10. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
    Obstet Gynecol. 2021;137:e100-e115.
    PubMed     Abstract available



  11. Access to Postpartum Sterilization: ACOG Committee Opinion, Number 827.
    Obstet Gynecol. 2021;137:e169-e176.
    PubMed     Abstract available


    May 2021
  12. HAMDAOUI N, Cardinale C, Fabre C, Baumstarck K, et al
    Pain Associated With Cervical Priming for First-Trimester Surgical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2021 May 6. pii: 00006250-990000000-00191.
    PubMed     Abstract available


    April 2021
  13. COLEMAN-MINAHAN K, Ela EJ, White K, Grossman D, et al
    Contraindications to Hormonal Contraception Among Postpartum Women in Texas.
    Obstet Gynecol. 2021 Apr 8. pii: 00006250-990000000-00175.
    PubMed     Abstract available


  14. ALLANSON ER, Copson S, Spilsbury K, Criddle S, et al
    Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial.
    Obstet Gynecol. 2021 Apr 8. pii: 00006250-990000000-00158.
    PubMed     Abstract available


  15. COHEN M, Edelman A, Bellussi F, Berghella V, et al
    Cochrane Review Summaries-April 2021.
    Obstet Gynecol. 2021;137:747-749.
    PubMed     Abstract available


    March 2021
  16. MEURICE ME, Lovio M, Chang JJ, Perry R, et al
    Contraception Choice Among Those Seeking Abortion for Fetal Indication or Management of Pregnancy Loss.
    Obstet Gynecol. 2021 Mar 10. pii: 00006250-990000000-00125.
    PubMed     Abstract available


  17. BORAAS CM, Sanders JN, Schwarz EB, Thompson I, et al
    Risk of Pregnancy With Levonorgestrel-Releasing Intrauterine System Placement 6-14 Days After Unprotected Sexual Intercourse.
    Obstet Gynecol. 2021 Mar 10. pii: 00006250-990000000-00136.
    PubMed    



  18. Health Care for Transgender and Gender Diverse Individuals: ACOG Committee Opinion, Number 823.
    Obstet Gynecol. 2021;137:e75-e88.
    PubMed     Abstract available


    February 2021
  19. AKTURK HK
    Locating Hormone-Releasing Contraceptive Implants Using Near-Infrared Light.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00117.
    PubMed     Abstract available


  20. ROLAND N, Drouin J, Desplas D, Cuenot F, et al
    Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00100.
    PubMed    


    January 2021

  21. Options for Prevention and Management of Menstrual Bleeding in Adolescent Patients Undergoing Cancer Treatment: ACOG Committee Opinion, Number 817.
    Obstet Gynecol. 2021;137:e7-e15.
    PubMed     Abstract available


    December 2020
  22. GOLDMAN AR, Porsch L, Hintermeister A, Dragoman M, et al
    Transcutaneous Electrical Nerve Stimulation to Reduce Pain With Medication Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020 Dec 3. doi: 10.1097/AOG.0000000000004208.
    PubMed     Abstract available


    November 2020

  23. Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion, Number 813.
    Obstet Gynecol. 2020;136:e90-e99.
    PubMed     Abstract available



  24. Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion Summary, Number 813.
    Obstet Gynecol. 2020;136:1072-1073.
    PubMed     Abstract available


    October 2020
  25. FERRIES-ROWE E, Corey E, Archer JS
    Primary Dysmenorrhea: Diagnosis and Therapy.
    Obstet Gynecol. 2020 Oct 8. doi: 10.1097/AOG.0000000000004096.
    PubMed     Abstract available



  26. Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin Summary, Number 225.
    Obstet Gynecol. 2020;136:855-858.
    PubMed     Abstract available


    September 2020
  27. BERKLEY HH, Greene HL, Wittenberger MD
    Mifepristone Combination Therapy Compared With Misoprostol Monotherapy for the Management of Miscarriage: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2020 Sep 10. doi: 10.1097/AOG.0000000000004063.
    PubMed     Abstract available


    August 2020
  28. CREININ MD, Grossman DA
    Medication Abortion Up to 70 Days of Gestation.
    Obstet Gynecol. 2020 Aug 12. doi: 10.1097/AOG.0000000000004082.
    PubMed     Abstract available


  29. LEININGER WM, Gupta P
    One Hundred Years of Women's Suffrage: Health Care Advocacy, and Why We Vote.
    Obstet Gynecol. 2020;136:349-353.
    PubMed     Abstract available


    July 2020
  30. EDELMAN AB, Kaneshiro B, Simmons KB, Hauschildt JL, et al
    Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users: A Randomized Controlled Trial.
    Obstet Gynecol. 2020 Jul 9. doi: 10.1097/AOG.0000000000003896.
    PubMed     Abstract available


    June 2020
  31. BARBIERI JS, Mitra N, Margolis DJ, Harper CC, et al
    Influence of Contraception Class on Incidence and Severity of Acne Vulgaris.
    Obstet Gynecol. 2020;135:1306-1312.
    PubMed     Abstract available


  32. SPOTNITZ ME, Natarajan K, Ryan PB, Westhoff CL, et al
    In Reply.
    Obstet Gynecol. 2020;135:1487.
    PubMed    


  33. SEL G, Yasar O, Aynali B, Dincer F, et al
    Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.
    Obstet Gynecol. 2020;135:1486-1487.
    PubMed    


  34. SIMON JA, Al-Hendy A, Archer DF, Barnhart KT, et al
    Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
    Obstet Gynecol. 2020;135:1313-1326.
    PubMed     Abstract available


  35. FLOYD JL, Beasley AD, Swaim LS, Turrentine MA, et al
    Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Obstet Gynecol. 2020;135:1275-1280.
    PubMed     Abstract available


    May 2020

  36. Gynecologic Management of Adolescents and Young Women With Seizure Disorders: ACOG Committee Opinion, Number 806.
    Obstet Gynecol. 2020;135:e213-e220.
    PubMed     Abstract available



  37. Gynecologic Management of Adolescents and Young Women With Seizure Disorders: ACOG Committee Opinion Summary, Number 806.
    Obstet Gynecol. 2020;135:1242-1243.
    PubMed     Abstract available


    April 2020
  38. LATHROP E, Hurst S, Mendoza Z, Zapata LB, et al
    Final Program Data and Factors Associated With Long-Acting Reversible Contraception Removal: The Zika Contraception Access Network.
    Obstet Gynecol. 2020 Apr 9. doi: 10.1097/AOG.0000000000003835.
    PubMed     Abstract available


  39. DARWIN KC, Johnson CT
    Desired Sterilization Procedure at the Time of Cesarean Delivery According to Insurance Status.
    Obstet Gynecol. 2020;135:976.
    PubMed    


  40. CREININ MD, Hou MY, Dalton L, Steward R, et al
    In Reply.
    Obstet Gynecol. 2020;135:970-971.
    PubMed    


  41. VALLEY MT
    Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020;135:970.
    PubMed    


  42. BUTTERFIELD-KALK CR
    Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020;135:970.
    PubMed    


  43. DELGADO G, Davenport M, Harrison M
    Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020;135:969-970.
    PubMed    


    March 2020
  44. STEINBERG JR, Harrison EY, Boudreaux M
    Psychosocial Factors Associated With Postpartum Contraceptive Method Use After an Unintended Birth.
    Obstet Gynecol. 2020 Mar 10. doi: 10.1097/AOG.0000000000003745.
    PubMed     Abstract available


    February 2020
  45. SPOTNITZ ME, Natarajan K, Ryan PB, Westhoff CL, et al
    Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.
    Obstet Gynecol. 2020 Feb 9. doi: 10.1097/AOG.0000000000003656.
    PubMed     Abstract available


  46. MACAFEE LK, Harfmann RF, Cannon LM, Kolenic G, et al
    Sexual and Reproductive Health Characteristics of Women in Substance Use Treatment in Michigan.
    Obstet Gynecol. 2020;135:361-369.
    PubMed     Abstract available


    January 2020

  47. Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population: Correction.
    Obstet Gynecol. 2020;135:222.
    PubMed    


    December 2019
  48. CREININ MD, Hou MY, Dalton L, Steward R, et al
    Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2019 Dec 5. doi: 10.1097/AOG.0000000000003620.
    PubMed     Abstract available


    October 2019

  49. Over-the-Counter Access to Hormonal Contraception: ACOG Committee Opinion, Number 788.
    Obstet Gynecol. 2019;134:e96-e105.
    PubMed     Abstract available



  50. Over-the-Counter Access to Hormonal Contraception: ACOG Committee Opinion Summary, Number 788.
    Obstet Gynecol. 2019;134:886-887.
    PubMed     Abstract available


    September 2019

  51. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION, Number 785.
    Obstet Gynecol. 2019;134:e71-e83.
    PubMed     Abstract available



  52. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION SUMMARY, Number 785.
    Obstet Gynecol. 2019;134:658-659.
    PubMed     Abstract available


    June 2019
  53. AINSWORTH AJ, Baumgarten SC, Bakkum-Gamez JN, Vachon CM, et al
    Tubal Ligation and Age at Natural Menopause.
    Obstet Gynecol. 2019;133:1247-1254.
    PubMed     Abstract available


    April 2019
  54. HATFIELD JL
    Ulipristal Acetate for Symptomatic Uterine Leiomyomas: Neither the Long-Awaited Panacea, nor the Opening of Pandora's Box.
    Obstet Gynecol. 2019 Apr 5. doi: 10.1097/AOG.0000000000003238.
    PubMed    



  55. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
    Obstet Gynecol. 2019;133:e279-e284.
    PubMed     Abstract available


    March 2019
  56. WONG S, Naresh A
    Etonogestrel Subdermal Implant-Associated Regression of Endometrial Intraepithelial Neoplasia.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003152.
    PubMed     Abstract available


  57. SUDHOF L, Shah NT
    In Pursuit of Value-Based Maternity Care.
    Obstet Gynecol. 2019;133:541-551.
    PubMed     Abstract available


  58. TEPPER NK, Jeng G, Curtis KM, Boutot ME, et al
    Venous Thromboembolism Among Women Initiating Depot Medroxyprogesterone Acetate Immediately Postpartum.
    Obstet Gynecol. 2019;133:533-540.
    PubMed     Abstract available


  59. BENLOLO S, Papillon-Smith J, Murji A
    Ulipristal Acetate for Disseminated Peritoneal Leiomyomatosis.
    Obstet Gynecol. 2019;133:434-436.
    PubMed     Abstract available



  60. ACOG Practice Bulletin No. 208: Benefits and Risks of Sterilization.
    Obstet Gynecol. 2019;133:e194-e207.
    PubMed     Abstract available



  61. ACOG Practice Bulletin No. 208 Summary: Benefits and Risks of Sterilization.
    Obstet Gynecol. 2019;133:592-594.
    PubMed     Abstract available


    February 2019
  62. GROSSMAN D, Grindlay K, Altshuler AL, Schulkin J, et al
    Induced Abortion Provision Among a National Sample of Obstetrician-Gynecologists.
    Obstet Gynecol. 2019 Feb 4. doi: 10.1097/AOG.0000000000003110.
    PubMed     Abstract available


  63. MAO J, Guiahi M, Chudnoff S, Schlegel P, et al
    Seven-Year Outcomes After Hysteroscopic and Laparoscopic Sterilizations.
    Obstet Gynecol. 2019;133:323-331.
    PubMed     Abstract available


  64. DIANAT S, Fox E, Ahrens KA, Upadhyay UD, et al
    Side Effects and Health Benefits of Depot Medroxyprogesterone Acetate: A Systematic Review.
    Obstet Gynecol. 2019;133:332-341.
    PubMed     Abstract available


    January 2019

  65. ACOG Committee Opinion No. 762: Prepregnancy Counseling.
    Obstet Gynecol. 2019;133:e78-e89.
    PubMed     Abstract available



  66. ACOG Committee Opinion No. 762 Summary: Prepregnancy Counseling.
    Obstet Gynecol. 2019;133:228-230.
    PubMed     Abstract available


  67. THORNE NB, Soderborg TK, Glover JJ, Hoffecker L, et al
    Reproductive Health Care in Catholic Facilities: A Scoping Review.
    Obstet Gynecol. 2019;133:105-115.
    PubMed     Abstract available


    December 2018

  68. ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent.
    Obstet Gynecol. 2018;132:e249-e258.
    PubMed     Abstract available



  69. ACOG Committee Opinion No. 760 Summary: Dysmenorrhea and Endometriosis in the Adolescent.
    Obstet Gynecol. 2018;132:1517-1518.
    PubMed     Abstract available


    November 2018

  70. ACOG Practice Bulletin No. 200 Summary: Early Pregnancy Loss.
    Obstet Gynecol. 2018;132:1311-1313.
    PubMed     Abstract available


    October 2018
  71. CARR BR, Stewart EA, Archer DF, Al-Hendy A, et al
    Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002933.
    PubMed     Abstract available


  72. SONALKAR S, Hunter T, Gurney EP, McAllister A, et al
    A Decision Analysis Model of 1-Year Effectiveness of Intended Postplacental Compared With Intended Delayed Postpartum Intrauterine Device Insertion.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002926.
    PubMed     Abstract available


  73. LIU JH, Soper D, Lukes A, Gee P, et al
    Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002942.
    PubMed     Abstract available


    August 2018

  74. Early Pregnancy Loss.
    Obstet Gynecol. 2018 Aug 28. doi: 10.1097/AOG.0000000000002899.
    PubMed     Abstract available



  75. ACOG Committee Opinion No. 747: Gynecologic Issues in Children and Adolescent Cancer Patients and Survivors.
    Obstet Gynecol. 2018;132:e67-e77.
    PubMed     Abstract available


    May 2018
  76. AKERS AY, Harding J, Perriera LK, Schreiber C, et al
    Satisfaction With the Intrauterine Device Insertion Procedure Among Adolescent and Young Adult Women.
    Obstet Gynecol. 2018 May 7. doi: 10.1097/AOG.0000000000002596.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: